Tag: Accendra Health
In brief: Trace Medical acquisition, HealthTap launch, Accendra Health notice
October 13, 2026HME News Staff
WHITMORE LAKE, Mich. & SARASOTA, Fla. – Trace Medical has acquired a majority interest in LiViliti Health Products, Inc. The acquisition follows LiViliti receiving 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Paptizer 360 classified as a Class II Respiratory Accessory Microbial Reduction Device for CPAP equipment.
The acquisition builds upon the existing strategic investment between the two organizations, aligning Trace Medical’s expansive nationwide distribution...
Accendra Health on notice from NYSE
October 12, 2026HME News Staff
RICHMOND, Va. – Accendra Health, Inc. on Oct. 6, 2026, received a notice from the New York Stock Exchange notifying the company that it is not in compliance with the NYSE’s continued listing standards because the average closing price of the company’s Class A Common Stock was less than $1.00 per share over a consecutive 30 trading-day period. The notice does not result in the immediate delisting of the company’s Common Stock from the NYSE, said Accendra in a release posted...
In brief: Accendra Health CEO, Reliable Medical buy, SpinLife franchise
September 18, 2026HME News Staff
RICHMOND, Va. – Accendra Health has named Kenneth Gardner-Smith as its next president and CEO, succeeding Edward Pesicka, who announced his plans to retire in August.
Gardner-Smith, who has served on the company’s board of directors since March 2022, is expected to assume the role early in the fourth quarter of 2026. He currently serves as CEO of Veritas Veterinary Partners, a national specialty and emergency veterinary platform, where he spearheaded a strategy reset and executive...
Accendra Health names new CEO
September 17, 2026HME News Staff
RICHMOND, Va. – Accendra Health has named Kenneth Gardner-Smith as its next president and CEO, succeeding Edward Pesicka, who announced his plans to retire in August.
Gardner-Smith, who has served on the company’s board of directors since March 2022, is expected to assume the role early in the fourth quarter of 2026. He currently serves as CEO of Veritas Veterinary Partners, a national specialty and emergency veterinary platform, where he spearheaded a strategy reset and executive...
Accendra Health provides update on CEO transition, credit facility
August 17, 2026HME News Staff
RICHMOND, Va. – Accendra Health says it plans to name a successor to CEO Edward Pesicka by mid-September, positioning the company for a timely leadership transition ahead of his retirement at the end of the year. “The company’s board of directors has maintained a comprehensive, long-standing CEO succession planning process supported by leading executive search and advisory firms,” it stated. “Following Mr. Pesicka’s formal announcement of his intention to retire...
Accendra Health ready to put weak Q2 in rear view
August 14, 2026Theresa Flaherty
RICHMOND, Va. – Accendra Health’s second quarter results “did not meet expectations,” thanks to lower revenue growth and other challenges, but executives pointed to several growth opportunities in upcoming quarters and overall improvement in its sleep business as evidence of the company’s strength.
For the quarter, the company saw lower revenue growth, slower than-expected collection recovery and a delay in cost reduction initiatives, said Edward Pesicka, president...
In brief: XiFin & Notable Systems create alliance, Accendra Health seeks next CEO
August 12, 2026HME News Staff
SAN DIEGO and DENVER – XiFin and Notable Systems have announced a multi-year strategic alliance to develop and deliver purpose-built artificial intelligence (AI) capabilities across the XiFin Empower AI RCM ecosystem.
By combining Notable’s document intelligence with XiFin’s revenue cycle data, domain expertise and established workflow orchestration, the two companies say they are creating purpose-built AI capabilities that understand information, determine the appropriate action,...
Accendra Health adopts tax asset preservation plan
August 11, 2026HME News Staff
RICHMOND, Va. – Accendra Health’s board of directors has adopted a Section 382 Rights Agreement designed to protect long-term shareholder value by facilitating the company’s ability to preserve its net operating loss carryforwards (NOLs) and certain other tax attributes. Accendra Health says a company generally experiences an ownership change if the percentage of the value of its stock owned by certain “5-percent shareholders” increases by more than 50 percentage points...
Accendra Health: Expansion opportunities will emerge later in 2026, accelerate in 2027
August 10, 2026HME News Staff
RICHMOND, Va. – Accendra Health reported net revenue of $613.2 million for the second quarter of 2026 vs. $681.9 million for same period last year. Other financial results:
Loss from continuing operations, net of tax, GAAP: ($89.1 million) vs. ($83.8 million)
Adjusted (loss) income from continuing operations, net of tax, non-GAAP: ($14.3 million) vs. $20.5 million
Adjusted EBITDA, non-GAAP: $60.1 million vs. $96.6 million
Free cash flow, non-GAAP: ($25.1 million) vs. $15.2 million
Loss...
Accendra Health makes leadership appointments in IT, procurement
July 28, 2026HME News Staff
RICHMOND, Va. – Accendra Health has promoted Nicholas (Nick) Piecora to senior vice president & chief information officer, reporting to Edward Pesicka, president & CEO. It has also promoted Agnes Ansay to vice president & chief procurement officer, reporting to Jonathan Leon, executive vice president & CFO. These appointments, the company says, reflect a deliberate shift to better align strategy and execution as it continues its evolution as a pure play home-based care organization. Accendra...